Literature DB >> 20883172

Radiopharmacokinetics of radioiodine in the parotid glands after the administration of lemon juice.

Douglas Van Nostrand1, Varalakshmi Bandaru, Shyam Chennupati, Jason Wexler, Kanchan Kulkarni, Frank Atkins, Mihriye Mete, Gurudev Gadwale.   

Abstract

BACKGROUND: The ability of sialagogues to increase or decrease radiation induced-sialoadenitis and/or xerostomia after therapeutic administration of ¹³¹I is controversial. To evaluate this we measured the radiopharmacokinetics of ¹²³I in the parotid glands (PGs) after its administration of lemon juice (LJ).
METHODS: A retrospective review was performed on all patients who had a salivary gland scan performed before ¹³¹I therapy between July 2008 and April 2009 at the Washington Hospital Center. Two hours after ¹²³I was given orally, dynamic scintigraphy was initiated. Five milliliters of LJ was given 5 minutes later. Then, the patient was imaged for 1 hour (phase 1) at which point the sequence was repeated (phase 2). Twenty-three patients were studied. For each PG, the presence or absence of uptake was assessed, and based on background corrected counts, the mean, range, and standard deviation were determined for multiple radiopharmacokinetic parameters such as (i) percent radioiodine washout, (ii) time from LJ administration to re-accumulation of radioiodine to pre-LJ activity, and (iii) percent reduction in radiation absorbed dose to the PGs if LJ had been re-administered at the time the radioiodine activity re-accumulated to the pre-LJ activity.
RESULTS: The mean  ± one standard deviation and range for percent washout were 84%  ± 18% (35%-100%) and 83%  ±  21% (37%-100%) in phase 1 and 2, respectively. The times from LJ to re-accumulation of the radioiodine to the pre-LJ activity were 21  ± 10 minutes (4-45 minutes) and 40  ± 14 minutes (12-62 minutes) for phase 1 and 2, respectively. The estimated percent reduction in radiation absorbed dose to the PGs following the first and second administration of LJ was 37%  ± 14% (13%-93%) and 47% ± 16% (21%-97%), respectively.
CONCLUSIONS: The washout of radioiodine from the PGs is rapid but transient. Early repeat administration may result in continued and cumulative reduction of radiation absorbed dose in the PGs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20883172     DOI: 10.1089/thy.2009.0429

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

Review 1.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

2.  Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer.

Authors:  Donika Plyku; Robert F Hobbs; Kevin Huang; Frank Atkins; Carlos Garcia; George Sgouros; Douglas Van Nostrand
Journal:  J Nucl Med       Date:  2017-01-19       Impact factor: 10.057

3.  Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake.

Authors:  Hae Won Kim; Byeong-Cheol Ahn; Sang-Woo Lee; Jaetae Lee
Journal:  Thyroid       Date:  2012-04-23       Impact factor: 6.568

4.  Na+/I- symporter expression, function, and regulation in non-thyroidal tissues and impact on thyroid cancer therapy.

Authors:  Sissy M Jhiang; Jennifer A Sipos
Journal:  Endocr Relat Cancer       Date:  2021-09-03       Impact factor: 5.900

5.  Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy.

Authors:  Baiqiang Lin; Fuya Zhao; Yang Liu; Jiayu Sun; Jing Feng; Lei Zhao; Haoran Wang; Hongye Chen; Wei Yan; Xiao Guo; Shang Shi; Zhiyong Li; Shuang Wang; Yu Lu; Jianjun Zheng; Yunwei Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-26       Impact factor: 6.055

6.  Optimal administration time of vitamin C after 131I therapy in differentiated thyroid cancer based on propensity score matching.

Authors:  Ye Liu; Yuhua Wang; Wanchun Zhang
Journal:  Front Surg       Date:  2022-09-22

7.  Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging.

Authors:  Walter Jentzen; Marion Richter; James Nagarajah; Thorsten Dirk Poeppel; Wolfgang Brandau; Colin Dawes; Andreas Bockisch; Ina Binse
Journal:  EJNMMI Phys       Date:  2014-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.